Mr. Tetsuomi Takano, President and CEO, t2T Healthcare Inc., was invited by CMIC, a global CRO headquartered in Tokyo, to the Japan session at “2024 GCD (Global Clinical Development) Summit in China Bioweek”, which was held at Shanghai Zhangjiang Science Hall on Fri, 9 Aug 2024.

He made a presentation titled “Japan’s Update in Regulatory and Clinical Study Environments for Drug Development” to Chinese pharmaceutical companies.  Q&A and discussion of the session with CMIC Japan executives were very interactive with the audience.

t2T Healthcare Inc. hopes more and more foreign pharmaceutical companies will soon come to Japan for their clinical studies as well as launch of their products in the Japanese market.